Highlander Capital Management, LLC Pfizer Inc Transaction History

Highlander Capital Management, LLC

$245 Million
Q1 2024

A detailed history of Highlander Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Highlander Capital Management, LLC holds 61,324 shares of PFE stock, worth $1.71 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

61,324

Previous 37,669 62.8%

Holding current value

$1.71 Million

Previous $1.08 Million 56.92%

% of portfolio

0.69%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$25.89 - $29.73 $612,427 - $703,263	23,655 Added 62.8%	61,324 $1.7 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $331,851 - $431,038	12,700 Added 50.86%	37,669 $1.08 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $274,882 - $321,310	8,566 Added 52.22%	24,969 $828,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $10,836 - $12,537	-300 Reduced 1.8%	16,403 $601,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $24,068 - $29,381	-550 Reduced 3.19%	16,703 $731,000

Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $6,979 - $8,275	150 Added 0.88%	17,253 $905,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $27,450 - $34,014	-600 Reduced 3.39%	17,103 $885,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $2,066 - $3,062	-50 Reduced 0.28%	17,703 $1.05 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $195,916 - $220,954	-5,850 Reduced 24.78%	17,753 $643,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $200,820 - $255,360	-6,000 Reduced 20.27%	23,603 $869,000
Q3 2020 Nov 17, 2020	SELL	$31.75 - $37.25 $1,587 - $1,862	-50 Reduced 0.17%	29,603 $1.09 Million
Q2 2020 Aug 17, 2020	BUY	$30.12 - $36.54 $399,090 - $484,155	13,250 Added 80.78%	29,653 $970,000
Q1 2020 May 27, 2020	BUY	$27.03 - $38.62 $2,703 - $3,861	100 Added 0.61%	16,403 $535,000
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $16,460 - $18,680	-500 Reduced 2.98%	16,303 $639,000
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $38,988 - $50,556	-1,200 Reduced 6.67%	16,803 $604,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $15,000 - $16,480	-400 Reduced 2.17%	18,003 $765,000
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $8,617 - $10,452	-250 Reduced 1.34%	18,403 $811,000
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $139,925 - $162,332	4,385 Added 30.73%	18,653 $648,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $6,652 - $7,058	-200 Reduced 1.38%	14,268 $517,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $448,508 - $494,082	14,468	14,468 $517,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.

Account

Highlander Capital Management, LLC Pfizer Inc Transaction History